THEOPHYL-225 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Theophyl-225, and what generic alternatives are available?
Theophyl-225 is a drug marketed by Ortho Mcneil Pharm and is included in two NDAs.
The generic ingredient in THEOPHYL-225 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theophyl-225
A generic version of THEOPHYL-225 was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THEOPHYL-225?
- What are the global sales for THEOPHYL-225?
- What is Average Wholesale Price for THEOPHYL-225?
Summary for THEOPHYL-225
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 171 |
| Patent Applications: | 4,002 |
| DailyMed Link: | THEOPHYL-225 at DailyMed |
US Patents and Regulatory Information for THEOPHYL-225
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | THEOPHYL-225 | theophylline | ELIXIR;ORAL | 086485-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ortho Mcneil Pharm | THEOPHYL-225 | theophylline | TABLET;ORAL | 084726-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
